Xtant Medical Leaders to Present at Canaccord Genuity Annual Growth Conference

Xtant Medical's Participation at the Canaccord Genuity Conference

Xtant Medical Holdings, Inc. (NYSE American: XTNT), recognized for their commitment to innovative surgical solutions, is gearing up for the Canaccord Genuity 46th Annual Growth Conference. This prestigious event will take place from August 11-13, 2026, in Boston, Massachusetts. The conference will spotlight critical advancements and discussions relevant to the medical technology sector, particularly in surgical orthopedics.

Key Executives to Lead the Discussion
At the forefront of Xtant Medical's presentation will be Sean Browne, CEO; Scott Neils, CFO; and Mark Schallenberger, COO. Together, they will delve into the company's latest developments and future strategies aimed at enhancing spinal and orthopedic solutions. Their presentation is slated for August 11th at 2:00 PM ET, and it promises to engage investors eager to learn about Xtant's innovative approaches to medical technology.

Live Webcast Availability
For those unable to attend in person, Xtant Medical plans to provide a live webcast of their presentation, highlighting vital insights and future growth strategies. The webcast will be accessible through the company’s investors’ website. Furthermore, a replay will be available for 90 days for continued access to the invaluable information shared during the presentation.

Meeting Opportunities with Management
Investors interested in concluding one-on-one meetings with Xtant's executives during the conference can arrange these discussions through their Canaccord Genuity representatives. This is a unique chance to gain deeper insights into Xtant Medical’s operations and strategic plans.

About Xtant Medical
Xtant Medical is driven by a profound mission to honor the gift of donation through advanced medical solutions that foster improved quality of life for patients. With a comprehensive portfolio of orthobiologics, spinal implant systems, and a focus on chronic and surgical wound care, Xtant is at the forefront of medical technology. The company's dedication is reflected in its commitment to integrity and customer service, ensuring that patients receive the highest level of care.

By participating in significant forums like this conference, Xtant Medical not only showcases its innovative capabilities but also reinforces its position as a leader in the medical technology landscape. As healthcare continues to evolve, Xtant’s contributions remain pivotal in developing cutting-edge solutions that meet patient needs and improve surgical outcomes.

Conclusion
Attendance at the Canaccord Genuity 46th Annual Growth Conference offers a platform for Xtant Medical to showcase its advancements and engage with investors. This underscores their commitment to continual growth and development in the medical technology sector. As the event approaches, anticipation builds around the exciting innovations that Xtant Medical will unveil during their presentation.